Dorsey Wright & Associates Regeneron Pharmaceuticals, Inc. Transaction History

Dorsey Wright & Associates

  • $376 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021
SELL
$478.3 - $607.98 $1.76 Million - $2.23 Million
-3,671 Closed
0 $0
Q3 2020

Oct 28, 2020
BUY
$544.75 - $658.21 $28,871 - $34,885
53 Added 1.46%
3,671 $2.06 Million
Q2 2020

Jul 23, 2020
BUY
$493.32 - $643.92 $1.78 Million - $2.33 Million
3,618 New
3,618 $2.26 Million

Others Institutions Holding REGN

# of Institutions
1,464
Shares Held
84.4M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $109B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email